Stay Alert for Heart Patients Getting Clarithromycin

You'll hear about an increased risk of heart problems or death with clarithromycin (Biaxin) in heart patients...due to a new FDA warning.

Researchers are puzzled about the mechanism. And many experts are skeptical...the studies have flaws, and not all show a long-term risk.

Until we know more, we're telling pharmacists to consider a "better safe than sorry" approach with clarithromycin Rxs.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote